Європейський Союз - словенська - EMA (European Medicines Agency)

novartis europharm ltd - aliskiren, amlodipine - hipertenzija - sredstva, ki delujejo na sistem renin-angiotenzin - zdravilo rasilamlo je indicirano za zdravljenje esencialne hipertenzije pri odraslih bolnikih, pri katerih krvni tlak ni ustrezno nadzorovan z uporabo aliskirena ali amlodipina.

Європейський Союз - словенська - EMA (European Medicines Agency)

novartis europharm ltd. - aliskiren - hipertenzija - sredstva, ki delujejo na sistem renin-angiotenzin - zdravljenje esencialne hipertenzije.

Словенія - словенська - Ecolab

ecolab deutschland gmbh -

Словенія - словенська - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lenalidomid - kapsula, trda - lenalidomid 10 mg / 1 kapsula - lenalidomid

Словенія - словенська - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lenalidomid - kapsula, trda - lenalidomid 15 mg / 1 kapsula - lenalidomid

Словенія - словенська - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lenalidomid - kapsula, trda - lenalidomid 25 mg / 1 kapsula - lenalidomid

Словенія - словенська - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lenalidomid - kapsula, trda - lenalidomid 5 mg / 1 kapsula - lenalidomid

Європейський Союз - словенська - EMA (European Medicines Agency)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - imunosupresivi - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indiciran za zdravljenje odraslih bolnikov s predhodno nezdravljenih več plazmocitom, ki niso primerni za presaditev. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indiciran za zdravljenje odraslih bolnikov s predhodno nezdravljenih več plazmocitom, ki niso primerni za presaditev. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Словенія - словенська - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lenalidomid - kapsula, trda - lenalidomid 10 mg / 1 kapsula - lenalidomid